Assessing the quality of life of postmenopausal women randomized into the ATAC (“arimidex”, tamoxifen, alone or in combination) adjuvant breast cancer trial
L. Fallowfield, D. CellaVolume:
12
Year:
2003
Language:
english
Pages:
1
DOI:
10.1016/s0960-9776(03)80136-4
File:
PDF, 223 KB
english, 2003